These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10486935)

  • 1. Extended recombinant bacterial ghost system.
    Lubitz W; Witte A; Eko FO; Kamal M; Jechlinger W; Brand E; Marchart J; Haidinger W; Huter V; Felnerova D; Stralis-Alves N; Lechleitner S; Melzer H; Szostak MP; Resch S; Mader H; Kuen B; Mayr B; Mayrhofer P; Geretschläger R; Haslberger A; Hensel A
    J Biotechnol; 1999 Aug; 73(2-3):261-73. PubMed ID: 10486935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for combination vaccines based on the extended recombinant bacterial ghost system.
    Eko FO; Witte A; Huter V; Kuen B; Fürst-Ladani S; Haslberger A; Katinger A; Hensel A; Szostak MP; Resch S; Mader H; Raza P; Brand E; Marchart J; Jechlinger W; Haidinger W; Lubitz W
    Vaccine; 1999 Mar; 17(13-14):1643-9. PubMed ID: 10194817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial ghosts as multifunctional vaccine particles.
    Szostak MP; Mader H; Truppe M; Kamal M; Eko FO; Huter V; Marchart J; Jechlinger W; Haidinger W; Brand E; Denner E; Resch S; Dehlin E; Katinger A; Kuen B; Haslberger A; Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):191-6. PubMed ID: 9382740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial ghosts: non-living candidate vaccines.
    Szostak MP; Hensel A; Eko FO; Klein R; Auer T; Mader H; Haslberger A; Bunka S; Wanner G; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):161-70. PubMed ID: 8717400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bacterial Ghost platform system: production and applications.
    Langemann T; Koller VJ; Muhammad A; Kudela P; Mayr UB; Lubitz W
    Bioeng Bugs; 2010; 1(5):326-36. PubMed ID: 21326832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial ghosts as adjuvant particles.
    Riedmann EM; Kyd JM; Cripps AW; Lubitz W
    Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial ghosts as vaccine candidates for veterinary applications.
    Jalava K; Hensel A; Szostak M; Resch S; Lubitz W
    J Control Release; 2002 Dec; 85(1-3):17-25. PubMed ID: 12480307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development.
    Eko FO; Szostak MP; Wanner G; Lubitz W
    Vaccine; 1994 Oct; 12(13):1231-7. PubMed ID: 7530888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of membrane-anchored flagellin into Salmonella Gallinarum bacterial ghosts induces early immune responses and protection against fowl typhoid in young layer chickens.
    Hajam IA; Kim JH; Lee JH
    Vet Immunol Immunopathol; 2018 May; 199():61-69. PubMed ID: 29678231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial ghosts as antigen delivery vehicles.
    Mayr UB; Walcher P; Azimpour C; Riedmann E; Haller C; Lubitz W
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1381-91. PubMed ID: 15878634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and immunity effect evaluation of biotechnology-derived Aeromonas veronii ghost by PhiX174 gene E-mediated inactivation in koi (Cyprinus carprio koi).
    Jiang N; Luo L; Xing W; Li T; Yuan D; Xu G; Li W; Ma Z; Jin L; Ji M
    Fish Shellfish Immunol; 2019 Mar; 86():327-334. PubMed ID: 30041051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of ghost vaccines trials.
    Batah AM; Ahmad TA
    Expert Rev Vaccines; 2020 Jun; 19(6):549-562. PubMed ID: 32500816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26.
    Riedmann EM; Kyd JM; Smith AM; Gomez-Gallego S; Jalava K; Cripps AW; Lubitz W
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):185-92. PubMed ID: 12832124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhanced immune responses induced by Salmonella enteritidis ghosts loaded with Neisseria gonorrhoeae porB against Salmonella in mice.
    Jiao H; Yang H; Zhao D; He L; Chen J; Li G
    FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27797865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial ghosts as carrier and targeting systems.
    Lubitz W
    Expert Opin Biol Ther; 2001 Sep; 1(5):765-71. PubMed ID: 11728212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).
    Walcher P; Cui X; Arrow JA; Scobie S; Molinia FC; Cowan PE; Lubitz W; Duckworth JA
    Vaccine; 2008 Dec; 26(52):6832-8. PubMed ID: 18948157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of bacterial ghosts in biomedicine.
    Lubitz P; Mayr UB; Lubitz W
    Adv Exp Med Biol; 2009; 655():159-70. PubMed ID: 20047041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotransporter-based antigen display in bacterial ghosts.
    Hjelm A; Söderström B; Vikström D; Jong WS; Luirink J; de Gier JW
    Appl Environ Microbiol; 2015 Jan; 81(2):726-35. PubMed ID: 25398861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.